Medical News

RSS

Sonomax signs MOU with ETS for $750,000 Industrial Research Chair

Sonomax Technologies Inc. signs a memorandum of understanding with the École de Technologie Supérieure (ETS) of the Université du Québec to create a five-year renewable $750,000 Industrial Research Chair to conduct unprecedented development of advanced in-ear technologies.

9 Jun 2010

Intellect Neurosciences receives Notice of Allowance from Israeli patent office for OXIGON drug candidate

Intellect Neurosciences, Inc announced it has received a Notice of Allowance from the Israeli Patent and Trademark Office for a new patent related to the Company's clinical-stage drug candidate OX1 (OXIGON), which has disease-modifying potential for Alzheimer's and other neurodegenerative disorders.

9 Jun 2010

Scientists develop algorithm to predict gene sequence of kinases

Kinexus Bioinformatics Corporation, a world-leader in molecular communications research, announced major advancements in its PhosphoNET KnowledgeBase for the study of cell signalling systems. This free resource to the scientific community now features data on more than 92,000 human phosphorylation sites, including their occurrence in over 20 other diverse species, and identification of the protein kinases that target these regulatory sites.

9 Jun 2010

Premier health alliance honors Standard Register with Supplier Performance Award for 5th consecutive year

For the fifth consecutive year, Standard Register is being honored by the Premier health alliance with its Supplier Performance Award at the 2010 Premier Annual Breakthroughs Conference and Exhibition in Washington D.C. The award ceremony is being held at the Gaylord National Hotel and Convention Center today, June 9.

9 Jun 2010

ISMP Canada develops new website to help consumers report medication incidents

The Institute for Safe Medication Practices Canada, has worked with Patients for Patient Safety Canada, Best Medicines Coalition and other consumer and patient groups to launch an initiative aimed at engaging patients in efforts to prevent harm from medication errors. A new website, www.SafeMedicationUse.ca, developed with support from Health Canada, provides a way for consumers to report medication incidents to ISMP Canada.

9 Jun 2010

S*BIO completes enrollment in SB1518 JAK2 inhibitor Phase 2 clinical trials for myelofibrosis

S*BIO Pte Ltd today announced that it has completed enrollment of patients in two separate Phase 2 clinical trials for its potent and orally-active JAK2 inhibitor SB1518 at multiple clinical sites in the U.S. and Australia for the treatment of myelofibrosis (MF).

9 Jun 2010

First clinical trial among African women to test vaginal ring that prevents HIV transmission

The nonprofit International Partnership for Microbicides today announced the initiation of the first trial among women in Africa testing a vaginal ring containing an antiretroviral drug that could one day be used to prevent HIV transmission during sex. The clinical trial, known as IPM 015, tests the safety and acceptability of an innovative approach that adapts a successful technology from the reproductive health field to give women around the world a tool to protect themselves from HIV infection.

9 Jun 2010

Repligen's fiscal 2010 total revenue decreases to $20,971,000

Repligen Corporation today reported results for the fourth quarter and fiscal year 2010, ended March 31, 2010. Total revenue for the year was $20,971,000 compared to total revenue of $29,362,000 for fiscal year 2009 ended March 31, 2009.

9 Jun 2010

HHS Secretary statement on new study that underscores urgency for reducing HAIs in ASCs

"Today, the Journal of the American Medical Association published a new study from the Centers for Disease Control and Prevention and the Centers for Medicare & Medicaid Services, which underscored the urgency behind the Obama Administration's efforts to reduce healthcare-associated infections.

9 Jun 2010

Enavail to build new cGMP facility in Abilene Life Sciences Accelerator

Enavail, LLC, a particle engineering company founded on pioneering drug delivery research from the University of Texas at Austin, announced today the company's plans for the construction of a new state-of-the-art current Good Manufacturing Practices (cGMP) facility in the Abilene Life Sciences Accelerator (ALSA). The Enavail facility will be the first of its kind in the West Texas region.

9 Jun 2010

Discovery Labs reports preliminary results from Surfaxin Phase 2 trial in children with Acute Respiratory Failure

Discovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxin® in children with Acute Respiratory Failure (ARF), a critical condition often caused in children by severe respiratory infections. The objective of the study was to evaluate the safety and tolerability of intratracheal administration of Surfaxin and to assess whether Surfaxin treatment could decrease the duration of mechanical ventilation in children with ARF.

9 Jun 2010

Accuray forms strategic alliance with Siemens

Accuray, a global leader in the field of radiosurgery, today announced that it has formed a strategic alliance with Siemens. The strategic alliance is expected to extend the global sales reach for Accuray's CyberKnife Robotic Radiosurgery System while creating a research-and-development alliance aimed at developing and commercializing innovative new technologies and products.

9 Jun 2010

Cardinal Health to purchase Healthcare Solutions Holding for $517M

Cardinal Health today announced plans to expand its presence in specialty pharmaceutical services with a definitive agreement to purchase Healthcare Solutions Holding, LLC in an upfront $517 million all-cash transaction. The agreement also includes the opportunity for earn-out payments of up to $150 million over the next three years.

9 Jun 2010

Correlogic Systems' OvaCheck blood test for detection of epithelial ovarian cancer receives CE Mark

Correlogic Systems, Inc. announced today that OvaCheck, the company's blood test for the detection of epithelial ovarian cancer, has fulfilled European Union regulatory requirements (CE marking) for distribution and sale of the test. The path is now cleared for the test to be made available to patients in Europe through their physicians.

9 Jun 2010

PulmoBind product candidate has potential for early diagnosis of PH in pediatric population

Pulmo BioTech Inc. has announced that early indications are that its PulmoBind product candidate has the potential for early diagnosis of Pulmonary Hypertension in the pediatric population. PH is a potentially life threatening and crippling disease; it is also very hard to diagnose.

9 Jun 2010

CGH, FISH techniques effective for postmortem analysis of fetuses, infants with congenital anomalies

New techniques to detect chromosomal abnormalities can offer a higher degree of accuracy. Chromosomal abnormalities are a well-known cause of multiple congenital anomalies, and conventional methods of culture analysis have proven unsuccessful in 10% to 40% of cases. Comparative genomic hybridization (CGH) and fluorescent in situ hybridization (FISH) techniques were tested and found successful by analyzing tissue from children who had multiple congenital anomalies.

9 Jun 2010

New AAN guideline provides step-by-step process for determining brain death in adults

In an effort to create a uniform and accurate method for determining brain death, the American Academy of Neurology has issued an updated guideline that provides doctors with a step-by-step process for determining brain death in adults. The guideline is published in the June 8, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.

9 Jun 2010

CXCR4 protein restores brain damage in multiple sclerosis patients

A protein that helps build the brain in infants and children may aid efforts to restore damage from multiple sclerosis (MS) and other neurodegenerative diseases, researchers at Washington University School of Medicine in St. Louis have found.

9 Jun 2010

RCSI scientists make breakthrough in understanding human adaptation to high altitude environments

A group of top international scientists including geneticists from the Royal College of Surgeons in Ireland has made a breakthrough in understanding human adaptation to high altitude environments.

9 Jun 2010

DuPont reaches regulatory milestone with confirmation of Plenish high oleic soybean trait

DuPont announced it has reached a regulatory milestone and the final step of the U.S. regulatory process with confirmation from the United States Department of Agriculture that its Plenish high oleic soybean trait has been approved for cultivation in the United States.

9 Jun 2010

Medical News

Sonomax signs MOU with ETS for $750,000 Industrial Research Chair

Intellect Neurosciences receives Notice of Allowance from Israeli patent office for OXIGON drug candidate

Scientists develop algorithm to predict gene sequence of kinases

Premier health alliance honors Standard Register with Supplier Performance Award for 5th consecutive year

ISMP Canada develops new website to help consumers report medication incidents

S*BIO completes enrollment in SB1518 JAK2 inhibitor Phase 2 clinical trials for myelofibrosis

First clinical trial among African women to test vaginal ring that prevents HIV transmission

Repligen's fiscal 2010 total revenue decreases to $20,971,000

HHS Secretary statement on new study that underscores urgency for reducing HAIs in ASCs

Enavail to build new cGMP facility in Abilene Life Sciences Accelerator

Discovery Labs reports preliminary results from Surfaxin Phase 2 trial in children with Acute Respiratory Failure

Accuray forms strategic alliance with Siemens

Cardinal Health to purchase Healthcare Solutions Holding for $517M

Correlogic Systems' OvaCheck blood test for detection of epithelial ovarian cancer receives CE Mark

PulmoBind product candidate has potential for early diagnosis of PH in pediatric population

CGH, FISH techniques effective for postmortem analysis of fetuses, infants with congenital anomalies

New AAN guideline provides step-by-step process for determining brain death in adults

CXCR4 protein restores brain damage in multiple sclerosis patients

RCSI scientists make breakthrough in understanding human adaptation to high altitude environments

DuPont reaches regulatory milestone with confirmation of Plenish high oleic soybean trait

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News